You are here: Industry Insights > EU

News List

European Union Opens Doors to American Travelers drugs
June 21, 2021
The European Union announced Friday that it will no longer ban U.S. tourists from traveling to Europe.
European Union to Lift Restrictions on U.S. Travelers drugs
June 17, 2021
Restrictions on U.S. travelers to the European Union should be lifted, ambassadors in the 27-member bloc decided Wednesday.
EU regulators release medicine demand forecasting guidance for future crises europeanpharmaceuticalreview
June 08, 2021
The new recommendations, developed in the context of the COVID-19 pandemic, are designed to help countries and other stakeholders forecast demand of medicines in future pandemics.
EU clears Tagrisso for early-stage EGFR-mutated lung cancer pharmatimes
June 01, 2021
The European Commission (EC) has approved AstraZeneca’s (AZ) Tagrisso for the adjuvant treatment of early-stage, epidermal growth factor receptor mutated (EGFR) non-small cell lung cancer (NSCLC) following surgery.
EU authorises Pfizer-BioNTech Covid-19 vaccine in adolescents pharmaceutical-technology
May 31, 2021
Pfizer and BioNTech have received expanded Conditional Marketing Authorization (CMA) in the European Union (EU) for their Covid-19 vaccine, Comirnaty, to include people aged 12 to 15 years.
EU’s Medical Device Regulation is now applicable europeanpharmaceuticalreview
May 28, 2021
Europe’s Medical Device Regulation is now applicable to medicines with an integral device, devices containing an ancillary medicinal substance and several other products.
EMA board confirms the EU clinical trial portal and database is fit for purpose europeanpharmaceuticalreview
April 26, 2021
The adoption of the 2014 Clinical Trial Regulation moves one step closer as the EMA confirms a key aspect, the EU trials database and portal, is on track for implementation.
EU to support novel antibiotics with €20 million funding europeanpharmaceuticalreview
April 15, 2021
BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
Novartis bags EU, UK licences for MS therapy Kesimpta pharmatimes
April 09, 2021
Novartis has received green lights from both the European Commission and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to market its multiple sclerosis (MS) therapy Kesimpta (ofatumumab).
EU countries consent to share COVID-19 vaccines with member states in need expresspharma
April 06, 2021
Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10 million doses.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page